Microvesicles are present in body fluids such as blood and urine and can be used as biomarkers for diseases such as cancer, diabetes and cardiovascular disease. EMRP project Metrological characterisation of micro-vesicles from body fluids as non-invasive diagnostic biomarkers (HLT02 MetVes) aims to develop reliable, comparable and quantitative analysis of microvesicles, as current techniques are not accurate enough to make a reliable diagnosis.
HLT02 JRP-Partners will present results of the JRP at the congress. At the congress thousands of the world’s leading experts on thrombosis, haemostasis and vascular biology will come together to present the most recent advances, exchange the latest science and discuss the newest clinical applications designed to improve patient care.
